Deepseek launches China as big AI player: Wedbush's Dan Ives
Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...
Wedbush Remains a Buy on C3ai (AI)
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...
Wedbush Securities' Ives On AI, DeepSeek, Palantir, And The Next Big Tech Winners
Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...
Wedbush Sticks to Its Buy Rating for Pegasystems (PEGA)
Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...
Day One Biopharmaceuticals (NASDAQ:DAWN) Given Outperform Rating at Wedbush
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...
Legacy Firm Wedbush's First Ever ETF to Focus on AI
Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...
Apple says it will invest $500 billion in U.S. over the next 4 years and hire 20,000 workers
Apple plans to invest $500 billion domestically over the next four years and hire 20,000 additional workers in the U.S., the ...
Potential DOD budget cuts give Palantir 'more opportunity,' not less: Wedbush
If the Department of Defense goes through budget cuts as suggested by a leaked memo, Palantir Technologies (PLTR) would have ...
Why Nvidia (NVDA) Is Advancing Today
Generally, companies are spending 10%-15 of their budgets on AI, and NVDA should benefit from this trend, Wedbush believes.
FY2029 Earnings Estimate for AVTE Issued By Wedbush
Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...